Physician profile
Celene Lopez
NPI 1528831328
$1,541.18
in general payments reported to CMS, 2019-2025
9 companies · $742 in 2025
The $742 reported for 2025 was more than what 95% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.95 · 2023: $449 · 2024: $250 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $323.03 | 2023-2025 | Alhemo, Novoseven |
| Servier Pharmaceuticals LLC | $268.26 | 2024-2025 | |
| Syndax Pharmaceuticals, INC. | $259.65 | 2025 | Revuforj |
| Genzyme Corporation | $224.08 | 2023 | |
| Springworks Therapeutics, INC. | $159.06 | 2025 | Ogsiveo, Gomekli |
| Alexion Pharmaceuticals, INC. | $125.01 | 2023 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2022 | |
| Jazz Pharmaceuticals INC. | $63.55 | 2025 | |
| Uswm, LLC | $18.59 | 2024 | Iwilfin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celene Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.